| Name | Apria Healthcare Llc |
|---|---|
| Organization Name | Apria Healthcare Llc |
| Location | 2450 Smith St I-k, Kissimmee, Florida 34744 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (407) 297-0100 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
Hematopoietic stem cells are now routinely used to treat patients with cancers and other disorders of the blood and immune systems, but researchers knew little about the progenitor cells that give rise to them during embryonic development.
The pharmaceutical industry must ensure an improved record of delivery by providing high quality, cost effective solutions to well defined unmet needs. This can be achieved through strategic collaborations that strengthen disease knowledge and provide improved tools to strengthen therapeutic target validation and to monitor therapeutic efficacy, says Andy Dray, Chief Scientist at AstraZeneca.
From the time presidential candidate Theodore Roosevelt first discussed health care reform in 1912, the topic has been a precedent-setting issue in the U.S. The 2010 passage of health care legislation is no different, but has many Americans in a quandary about how it will affect them. This is especially true of senior citizens.
› Verified 5 days ago
| NPI Number | 1518191527 |
| Organization Name | APRIA HEALTHCARE LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2450 Smith St, Ste I-k, Kissimmee, FL 34744 |
| Phone Number | 407-297-0100 |
News Archive
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
Hematopoietic stem cells are now routinely used to treat patients with cancers and other disorders of the blood and immune systems, but researchers knew little about the progenitor cells that give rise to them during embryonic development.
The pharmaceutical industry must ensure an improved record of delivery by providing high quality, cost effective solutions to well defined unmet needs. This can be achieved through strategic collaborations that strengthen disease knowledge and provide improved tools to strengthen therapeutic target validation and to monitor therapeutic efficacy, says Andy Dray, Chief Scientist at AstraZeneca.
From the time presidential candidate Theodore Roosevelt first discussed health care reform in 1912, the topic has been a precedent-setting issue in the U.S. The 2010 passage of health care legislation is no different, but has many Americans in a quandary about how it will affect them. This is especially true of senior citizens.
› Verified 5 days ago
News Archive
A new report demonstrates that clinical and genetic factors affecting dose requirements for warfarin vary by race. The study, published online today in Blood, the Journal of the American Society of Hematology, proposes race-specific equations to help clinicians better calculate warfarin dosage.
Hematopoietic stem cells are now routinely used to treat patients with cancers and other disorders of the blood and immune systems, but researchers knew little about the progenitor cells that give rise to them during embryonic development.
The pharmaceutical industry must ensure an improved record of delivery by providing high quality, cost effective solutions to well defined unmet needs. This can be achieved through strategic collaborations that strengthen disease knowledge and provide improved tools to strengthen therapeutic target validation and to monitor therapeutic efficacy, says Andy Dray, Chief Scientist at AstraZeneca.
From the time presidential candidate Theodore Roosevelt first discussed health care reform in 1912, the topic has been a precedent-setting issue in the U.S. The 2010 passage of health care legislation is no different, but has many Americans in a quandary about how it will affect them. This is especially true of senior citizens.
› Verified 5 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2450 Smith St I-k, Kissimmee, Florida 34744 Phone: (407) 297-0100 | |
Publix Pharmacy #1181 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3839 Pleasant Hill Rd, Kissimmee, Florida 34746 Phone: (407) 343-7878 | |
Publix Pharmacy #1194 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3040 Dyer Blvd, Kissimmee, Florida 34741 Phone: (407) 933-1524 | |
Publix Pharmacy #1607 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3221 Vineland Rd, Kissimmee, Florida 34746 Phone: (407) 606-0035 | |
Cvs Pharmacy # 04128 Type: Pharmacy Location: 3250 N John Young Pkwy, Kissimmee, Florida 34741 Phone: (407) 933-0947 |